Published in Medical Letter on the CDC and FDA, July 1st, 2007
Doxycycline Tablets are the generic version of Par Pharmaceutical's Doxycycline Tablets, 150mg, marketed as Adoxa(R) Tablets by Doak Dermatologics. Doxycycline Tablets had U.S. sales of approximately $34 million for the 12 months ending March 31, 2007, for the 150 mg strength.
In addition to this new product strength, Mylan previously received approval and is marketing the 50 mg, 75 mg and 100 mg strengths of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.